Tenaya Therapeutics Inc (TNYA)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$0.32-14.57%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · TNYA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 61.1 | 68.6 | 86.7 | 98.0 | 94.5 | 54.4 | 31.1 |
| Operating Income | (104.5) | (93.3) | (115.9) | (131.2) | (125.6) | (72.8) | (38.9) |
| Earnings from Continuing Operations | |||||||
| Interest & Investment Income | 2.7 | 2.7 | 4.7 | 7.1 | 2.0 | 0.1 | 0.1 |
| Other Non-Operating Income / Expenses | 2.7 | 2.7 | 4.8 | 7.1 | 2.0 | 0.1 | 0.5 |
| EBT, Incl. Unusual Items | (101.8) | (90.6) | (111.1) | (124.1) | (123.7) | (72.7) | (38.4) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (101.8) | (90.6) | (111.1) | (124.1) | (123.7) | (72.7) | (38.4) |
| Per Share | |||||||
| Basic EPS | (0.45) | (0.59) | (1.31) | (1.68) | (2.76) | (4.10) | — |
| Diluted EPS | (0.45) | (0.59) | (1.31) | (1.68) | (2.76) | (4.10) | — |
| Basic Weighted Avg Shares | 226.0 | 153.0 | 84.8 | 73.8 | 44.8 | 17.7 | — |
| Diluted Weighted Avg Shares | 226.0 | 153.0 | 84.8 | 73.8 | 44.8 | 17.7 | — |
| Supplemental | |||||||
| EBITDA | — | (84.9) | (107.4) | (122.5) | (119.1) | (69.8) | (36.4) |
| EBIT | (104.5) | (93.3) | (115.9) | (131.2) | (125.6) | (72.8) | (38.9) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.